Skip to content
The Department of Neurology has a long and dynamic legacy of promoting diversity and inclusion in the workplace and health care setting.
Contact our scheduling team to make an in-person or Virtual Visit appointment
Learn about our Adult Neurology and Child Neurology Residency Programs.
Clinical trials are a key component of the research mission of the Department of Neurology at CUIMC
Showing 1 - 10 of 260 results.
Matthew B. Harms, MD, Associate Professor of Neurology, and Neil A. Shneider, MD, PhD, Claire Tow Associate Professor of Motor Neuron Disorders (in Neurology) comment on ALS research
The Economist covers some of Dritan Agalliu, PhD, Associate Professor of Pathology and Cell Biology in Neurology, research on the immune mechanisms
Martin Picard, PhD, Associate Professor of Behavioral Medicine in Psychiatry and Neurology, talks about how mitochondria are not just simple powerhouses of the cell.
Botanists are using technology made by Jennifer Gelinas, MD, PhD, Assistant Professor of Neurology & Dion Khodagholy, PhD, Associate Professor of Electrical Engineering, to understand the human brain
Jennifer J. Manly, PhD, Professor of Neuropsychology in Neurology, the Gertrude H. Sergievsky Center and the Taub Institute, research about the mediterranean diet & dementia
Joshua Z Willey, MD, an Associate Professor of Neurology at CUIMC, commented on Senator Mitch McConnell's recent medical episode.
New research evidence by David Sulzer, PhD and Dritan Agalliu, PhD back the hypothesis that what triggers initial gastrointestinal changes in Parkinson’s could be a misdirected immune attack
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences (in Neurology & in the Taub Institute) and colleagues discovered a mechanism that promotes neurogenesis in the zebrafish brain
Mitchell S.V. Elkind, MD, MS, MPhil commented on a new study according to which "Prescribing" fruits & vegetables to adults and children is associated with multiple health benefits
New findings by Columbia researchers Dritan Agalliu, PhD, and David Sulzer, PhD, are showing that what triggers initial gastrointestinal changes in Parkinson’s could be a misdirected immune attack